Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: East River Capital

East River Capital

posted on Mar 29, 2006 04:00PM
ERC now has control of X`s IP, the court has ok`d ERC`s DIP finance of X, that debt will be paid back, the court will make sure of it...There is only two ways, liqudate or sell new shares. ERC has the control.
Share
New Message
Please login to post a reply